Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

805 > Lecture 5 > Flashcards

Lecture 5 Flashcards

Coagulation

1
Q

Antiplatelets

A

Drugs that inhibit platelet activation, adhesion, & aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Anticoagulants

A

Drugs that inhibit clotting factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Types of Thrombus (2)

A
  1. Thrombus - adheres to vessel wall

2. Embolus - intravascular clot that floats in blood. Can lead to things like pulmonary embolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Antifibrinolytic

A

Drugs that inhibit the chemical transition of plasminogen to plasmin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Thrombosis Types (2)

A
  1. Arterial thrombosis - medium sized, due to artherosclerosis, platelet rich. Treated with platelet aggregation factors like aspirin
  2. Venous thrombosis - triggered by blood statis or disruption of hemostatic defense mechanisms. Fibrin rich clots with fewer platelets, treated with anticoagulants like warfarin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Platelets

A
  • function in hemostasis
  • cell fragments that shed from their parent cell that is confined in the bone marrow
  • parent cell = megakaryocyte
  • contain cytoplasm of parent
  • live ~10 days
  • 1/3 stored in spleen
  • sympathetic stimulation releases platelets
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Megakaryocyte

A
  • Massive cell (~60 um)
  • produce ~1000 platelets
  • thrombopoietin stimulates megakaryocyte differentiation & platelet products
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Platelet Anatomy

A
  • Have glycogen granules for energy
  • Mitochondria
  • Granules that contain activation factors
  • Open canalicular sytems (inverted socks) that, when activated, become pseudopodia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Step in Platelet Plug Formation (3)

A
  1. Vascular spasm
  2. Formation of platelet plug
  3. Blood coagulation (clotting)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Vascular Spasm

A
  • vasoconstriction

- endothelial surface adhesion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Platelet Plug Formation

A
  • exposed collagen activate platelets
  • platelets release ADP which activate adjacent platelets
  • reaction is contained in this area of damage via prostacyclin and NO
  • actin-myosin complex contracts and pulls the endothelial layers together
  • Vasoconstrictors released (serotonin, epi., TXA)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Blood Coagulation

A

Changes blood from liquid state to a solid clot

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Heparin Mechanism of Action

A

Directly inhibits thrombin & platelet aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Plavix Mechanism of Action

A

Inhibitor of platelet activation and aggregation by blocking the binding of P2Y metabolite to ADP which activates the surrounding platelets.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Tirofiban

A

Blocks the binding of fibrinogen to glycoprotein IIb/IIIa which inhibits platelet aggregation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Clotting Process

A
  1. Adhesion (to collagen)
  2. Activation
  3. Aggregation
  4. Clot
  5. Fibrinolysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Integrin Pathway (Activation)

A

After the platelet adheres to collagen, the [alpha]2[beta]3 receptor causes a cascade of actions that causes fibrinogen to unfold. This allows for platelet interactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Platelet Aggregation

A

Once fibrinogen is unfolded, there is cross linking of other activated platelets that create a net

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Agonists of Platelets (6)

A
  1. Adhesion
  2. Thrombin
  3. Thomboxane A2
  4. ADP
  5. Epinephrine
  6. Serotonin

Increased levels of these components lead to aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Factors Stopping Coagulation (4)

A
  1. Prostacyclin (PGI2) - antiaggregatory
  2. NO - vasodilatory
  3. tPA - Fibrinolytic
  4. Thrombomodulin - antithrombotic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Prostacyclin (PGI2)

A

Released by normal endothelial cells which activate cAMP in platelets and inhibits Ca+2. This inhibits platelet aggregation. Less PGI2 is released by damaged endothelial cells which decreases cAMP release and leads to platelet aggregation

22
Q

Thromboxane A2

A

Platelets react to this and it causes them to release granules containing ADP, platelet-activation factor, and thrombin. The release of these promote the conformational change in GP IIb/IIIa that allows for fibrinogen bonding and, by extension, platelet aggregation

23
Q

Platelet Aggregation Pathway

A
  1. Initial stimulation by collagen releases platelet activation factors
  2. Activates platelet membrane phospholipases
  3. Increases arachidonic acid in platelet
  4. Increases the synthesis of PGH2 by COX I
  5. Increases thromboxane A2 formation
  6. Increases platelet aggregation
24
Q

Aspirin Mechanism of Action

A

Blocks COX I inhibitors and the synthesis of PGH2. Lasts the lifetime of the platelet (~3-7 days) since it is unable to replace the COXI receptors.

25
Q

Salicylic Acid

A

Another COXI receptor blocker like aspirin but it is a reversible reaction. Only lasts a few hours

26
Q

Clot Formation Steps (3)

A
  1. Conversion of fibrinogen into fibrin which is catalyzed by thrombin.
  2. Fibrin forms a mesh/net at the injury site which traps platelets & RBCs
  3. Initial fibrin mesh is weak. Cross links rapidly form and strengthen the clot. This also enhances factor XIII which stabilizes fibrin.
27
Q

Thrombin’s Actions (5)

A
  1. Converts inactive fibrinogen into active fibrin
  2. Activates factor XIII
  3. Positive feedback conversion of prothrombin into thrombin
  4. Increases platelet aggregation
  5. Indirect: aggregated platelets secrete P3 which stimulates prothrombin to thrombin conversion
28
Q

2 Clotting Pathways

A
  1. Intrinsic - clotting within damaged vessel. All components in blood & blood is retained in vessels
  2. Extrinsic - tissue trama, tissue thromboplastin is released and takes a shortcut to retain blood in the tissue
29
Q

Where Clotting Pathways Merge

A

The extrinsic pathway releases tissue thromboplastin and the intrinsic pathway releases factor IX which both active factor X that goes on to catalyze the conversion of prothrombin to thrombin.

30
Q

Vessel Repair & Clot Dissolution Steps (3)

A
  1. Clots aren’t permanent. Platelets recruit fibroblasts which lay down connective tissue that later becomes a scar
  2. Plasmin is formed from plasminogen by the catalyzation of factor XII. Plasmin trapped in the fibrin mesh later dissolves it
  3. Leukocytes phagocytize the clot
31
Q

Thrombolytic Drugs

A

Streptokinase, Alteplase (tPA)

32
Q

Thrombolytic Drug Mechanism

A

Converts plasminogen to plasmin which cleaves fibrin and lyses the thrombi.

33
Q

Thrombolytic Drug Uses

A

Deep-vein thrombosis, weak MI, pulmonary embolisms

34
Q

Thrombolytic Drug Adverse Effects

A

Hemorrhaging, cardiovascular accidents, and complications with pregnancy and metastatic cancers.

35
Q

Fibrinogen Structure & Binding

A

Each molecule of fibrinogen has an E portion and due D domains. First they arrange in a D-E-D-D-E-D pattern. The E domain, by the end, binds to 6 D domain which causes D-dimers to form in response to factor XIIIa.

36
Q

APC

A

Activated Protein C. Anticoagulant that is upregulated by the activation of thrombin.

37
Q

APC Action

A

Inactivates factors VII & X. Increases endothelial barrier integrity and decreases endothelial inflammation. The latter lowers the adhesion of molecules and cytokines to the endothelium.

38
Q

Lab Tests for Coagulation Disorders (5)

A
  1. CBC - platelet count should be about 150,000-350,000/mm^3
  2. Bleeding time (not preferred)
  3. Prothrombin Time (preferred) - ~10-14 seconds and related to the extrinsic pathway function
  4. Activated Partial Thromboplastin Time - related to intrinsic pathway function
  5. Thrombin Time & D-Dimer - (<200 ng/mL) relates to the quality of fibrinogen & fibrinolysis
39
Q

Vascular Purpura & Petechiae

A
  • pinpoint to diffuse hemorrhages
  • breakdown of capillary endothelium barrier integrity
  • Autoimmune process but can also relate to Scurvy or drug-induced disorders
  • Looks like little red dots all over the skin
  • Occurs when platelet count is between 50,000-100,000/mm^3
40
Q

Reasons for Inappropriate Clot Formation - Thromboembolism (4)

A
  1. Roughened vessel surfaces (artherosclerosis)
  2. Imbalances of clotting-anticoagulation factors
  3. slow or stagnant blood
  4. Widespread release of tissue thromboplastin (septicemic shock)
41
Q

Prevention Against Thromboembolisms

A

Tissue Plasminogen activator - released by lungs and is circulated in low concentrations to prevent clotting

42
Q

Hemophilia

A

Cascade factor deficiency that leads to ineffective clotting. Most commonly is a lack of factor VIII

43
Q

Venous Thrombus

A
  • 3rd most common cardiovascular event after ACS/AMI & strokes
  • Can lead to immobility, obesity, inflammatory diseases, surgery, & trauma
  • Treatments: anticoagulants, antiplatelets, & surgery
44
Q

Hemostasis Dirorder Classifications (2)

A
  1. Inherited - hemophilias, platelet disorders, fibrinolytic dirorders, connective tissue disorders, vascular
  2. Acquired - liver diseases, renal failure, vitamin K deficiency, drug use, thrombocytopenia

All lead to increased bleeding

45
Q

Thrombocytopenia

A

-Platelet disorder
Causes:
-Decreased platelet production (marrow problem)
-Decreased platelet survival (drugs, heart valves (turbulence), pathogens)
-Splenic sequestration
-Platelet dilution (transfusions)

No symptoms until platelet count is <100,000/mm^3. Risk intracranial bleeding when count drops to ~20,000

46
Q

Hemophilia A

A
  • Coagulation disorder
  • accounts for ~85% of hemophilia patients
  • Deficiency of factor VIII
  • X-linked, recessive
47
Q

Hemophilia B

A
  • Coagulation disorder
  • factor IX deficiency
  • severe disorder that leaves the patient with only about 1% normal coagulation activity
  • Prolonged bleeding is the main issue causes by it, especially when its internal and undetected
  • Possible to give factor VIII prior to surgeries or dental procedures to minimize the prolonged bleeding
48
Q

Von Willebrand Disease

A
  • Coagulation disorder

- Decreased or absent vWF, a factor VIII carrier protein that aids in platelet adherence to damaged endothelioum

49
Q

Vitamin K Deficiency + Clotting

A

Can lead to coagulation problems since vitamin K is needed to synthesize factors II, VII, IX, & X

50
Q

Disseminated Intravascular Coagulation (DIC)

A

“Death is Coming”

  • Multiorgan dysfunction caused by multithrombi
  • bleeding caused by consumption of platelets, fibrinogen, & other coagulation factors
  • secondary fibrinolysis
51
Q

Algorithm for Diagnosing DIC

A

Series of yes/no questions where no gets zero points and yes usually gets 2 points. The higher the points by the end of the survey, the higher the mortality rate or percentage. Questions take into account the levels of blood components and prolonged prothrombin time.

805 (18 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions